Ge Y, Ma E, Guo X, Wang Q, Zhu W, Ren D
J Cell Mol Med. 2025; 29(4):e70388.
PMID: 39988987
PMC: 11847971.
DOI: 10.1111/jcmm.70388.
Liu B, Zheng J, Tang Z, Gao L, Wang M, Sun Y
BMC Cardiovasc Disord. 2025; 25(1):77.
PMID: 39901081
PMC: 11792395.
DOI: 10.1186/s12872-024-04445-2.
Hempel P, Ribeiro A, Vollmer M, Bender T, Dorr M, Krefting D
NPJ Digit Med. 2025; 8(1):25.
PMID: 39806125
PMC: 11730300.
DOI: 10.1038/s41746-024-01428-7.
Han X, Zhu Q, Li Z, He J, Sun Y, Zhong Q
Hypertens Res. 2024; 48(3):1054-1067.
PMID: 39715792
PMC: 11879844.
DOI: 10.1038/s41440-024-02068-w.
Qu Y, Ma D, Wu T, Wang H, Tian Z, Liu X
Sci Rep. 2024; 14(1):30379.
PMID: 39638825
PMC: 11621778.
DOI: 10.1038/s41598-024-81611-8.
Myoferlin alleviates pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting NLRP3-mediated pyroptosis.
Zhou Y, Liu Y, Luo H, Wen C, Cui Y, Du L
PeerJ. 2024; 12:e18499.
PMID: 39553724
PMC: 11568814.
DOI: 10.7717/peerj.18499.
The role of body composition in left ventricular remodeling, reverse remodeling, and clinical outcomes for heart failure with mildly reduced ejection fraction: more knowledge to the "obesity paradox".
Fu K, Dong Y, Wang Z, Teng J, Cheng C, Su C
Cardiovasc Diabetol. 2024; 23(1):334.
PMID: 39261931
PMC: 11391770.
DOI: 10.1186/s12933-024-02430-9.
Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases.
Dong W, Hu C, Hu M, Gao Y, Hu Y, Li K
Cell Commun Signal. 2024; 22(1):389.
PMID: 39103830
PMC: 11301845.
DOI: 10.1186/s12964-024-01767-8.
Recent advances of PIWI-interacting RNA in cardiovascular diseases.
Li B, Wang K, Cheng W, Fang B, Li Y, Yang S
Clin Transl Med. 2024; 14(8):e1770.
PMID: 39083321
PMC: 11290350.
DOI: 10.1002/ctm2.1770.
Low-Volume and High-Intensity Aerobic Interval Training May Attenuate Dysfunctional Ventricular Remodeling after Myocardial Infarction: Data from the INTERFARCT Study.
Aispuru-Lanche G, Gallego-Munoz M, Jayo-Montoya J, Villar-Zabala B, Maldonado-Martin S
Rev Cardiovasc Med. 2024; 24(1):20.
PMID: 39076876
PMC: 11270403.
DOI: 10.31083/j.rcm2401020.
U shape association between triglyceride glucose index and congestive heart failure in patients with diabetes and prediabetes.
Shi Y, Yu C
Nutr Metab (Lond). 2024; 21(1):42.
PMID: 38956581
PMC: 11221084.
DOI: 10.1186/s12986-024-00819-7.
USP38 exacerbates pressure overload-induced left ventricular electrical remodeling.
Pan Y, Xiao Z, Yang H, Kong B, Meng H, Shuai W
Mol Med. 2024; 30(1):97.
PMID: 38937697
PMC: 11210128.
DOI: 10.1186/s10020-024-00846-3.
Baicalin alleviates angiotensin II-induced cardiomyocyte apoptosis and autophagy and modulates the AMPK/mTOR pathway.
Cheng Y, Yan M, He S, Xie Y, Wei L, Xuan B
J Cell Mol Med. 2024; 28(9):e18321.
PMID: 38712979
PMC: 11075640.
DOI: 10.1111/jcmm.18321.
Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review).
Chen B, Guo J, Ye H, Wang X, Feng Y
Mol Med Rep. 2024; 29(5).
PMID: 38488029
PMC: 10955520.
DOI: 10.3892/mmr.2024.13197.
Left Ventricular Hypertrophy in Male and Female Judo Athletes.
Rossi C, Roklicer R, Drid P, Milovancev A, Trivic T, Scardina A
Int J Sports Med. 2024; 45(5):377-381.
PMID: 38401535
PMC: 11065483.
DOI: 10.1055/a-2252-1239.
Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice.
Sunagawa Y, Tsukabe R, Irokawa Y, Funamoto M, Suzuki Y, Yamada M
Int J Mol Sci. 2024; 25(4).
PMID: 38397020
PMC: 10889817.
DOI: 10.3390/ijms25042344.
Cardioprotective Effects of the GRK2 Inhibitor Paroxetine on Isoproterenol-Induced Cardiac Remodeling by Modulating NF-κB Mediated Prohypertrophic and Profibrotic Gene Expression.
Alonazi A, Bin Dayel A, Albuaijan D, Bin Osfur A, Hakami F, Alzayed S
Int J Mol Sci. 2023; 24(24).
PMID: 38139099
PMC: 10743803.
DOI: 10.3390/ijms242417270.
Semaphorin‑3A alleviates cardiac hypertrophy by regulating autophagy.
Sun Y, Dong J, Chai X, Wang J, Li B, Yang J
Exp Ther Med. 2023; 27(1):38.
PMID: 38125367
PMC: 10731408.
DOI: 10.3892/etm.2023.12326.
COX6A2 deficiency leads to cardiac remodeling in human pluripotent stem cell-derived cardiomyocytes.
Jiang M, Song Y, Chen X, Lu W, Zhu M, Wei M
Stem Cell Res Ther. 2023; 14(1):357.
PMID: 38072986
PMC: 10712066.
DOI: 10.1186/s13287-023-03596-x.
miR-455-5p promotes pathological cardiac remodeling via suppression of PRMT1-mediated Notch signaling pathway.
Cai S, Chang J, Su M, Wei Y, Sun H, Chen C
Cell Mol Life Sci. 2023; 80(12):359.
PMID: 37951845
PMC: 10640488.
DOI: 10.1007/s00018-023-04987-2.